- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Gonadotropin Hormone Therapy · Educational Resource
Understanding HCG and Fertility Hormone Research
Pharmacological Classification
Human chorionic gonadotropin (hCG), a glycoprotein hormone
Approved Clinical Applications
Hypogonadotropic hypogonadism and fertility protocol support
Administration Protocol
Subcutaneous injection, per physician-directed schedule
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Gonadotropin Hormone Therapy · Educational Resource
Understanding HCG and Fertility Hormone Research
01 — Overview
What is HCG?
Human chorionic gonadotropin (HCG) is a glycoprotein hormone naturally produced during pregnancy, but is also manufactured as an FDA-approved medication used to support reproductive hormone function in both men and women.
To understand its clinical role, it helps to think of HCG as a stand-in for luteinizing hormone (LH), the pituitary signal that tells the gonads to produce sex hormones. When the body's own LH signal is insufficient, HCG can step in to activate the same downstream receptors.
Unlike compounded investigational peptides, HCG is a mass-manufactured, FDA-approved medication with established clinical indications, including hypogonadotropic hypogonadism and ovulation induction. It remains available strictly by prescription and requires monitoring by a licensed physician.
02 — How it works
How It Works: Luteinizing Hormone Receptor Activation
The primary mechanism researchers evaluate when studying HCG is its capacity to bind to and activate luteinizing hormone (LH) receptors in the testes and ovaries, closely mimicking the body's natural LH signal.
In men, this receptor activation stimulates Leydig cells to produce testosterone and supports spermatogenesis, which is why HCG is frequently studied as an adjunct therapy to help preserve testicular function and fertility during testosterone replacement protocols.
Administration Guidance
HCG is administered via subcutaneous injection, typically on a schedule determined by the specific approved indication, such as fertility support or adjunctive testosterone replacement therapy protocols. Dosing frequency and duration are determined exclusively by a licensed prescribing physician based on individual hormone panels and treatment goals.
03 — Areas of research
Summary of Investigated Research Areas
Ongoing clinical research continues to evaluate HCG across several physiological systems, particularly relating to testicular function preservation, ovulatory induction, and fertility protocol optimization.
Testicular Testosterone Preservation
Clinical trials evaluate HCG's role in maintaining intratesticular testosterone during exogenous testosterone therapy.
Spermatogenesis Support
Studies examine HCG's effect on sperm production in men with hypogonadotropic hypogonadism.
Ovulation Induction
Research evaluates HCG's use in triggering ovulation as part of assisted reproductive protocols.
Combination TRT Protocols
Investigations assess co-administration of HCG alongside testosterone therapy to mitigate testicular atrophy.
Luteinizing Hormone Receptor Studies
Comparative research examines HCG's structural similarity to LH and its receptor-binding affinity.
Pediatric Cryptorchidism Research
Historical and clinical literature evaluates HCG's role in testicular descent in prepubertal boys.
04 — FAQ
Frequently Asked Questions
05 — References
References and Academic Literature
Coviello, A. D., Matsumoto, A. M., Bremner, W. J., et al. (2005). Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.. Journal of Clinical Endocrinology & Metabolism, 90(5), 2595-2602.
Depenbusch, M., von Eckardstein, S., Simoni, M., & Nieschlag, E. (2002). Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.. European Journal of Endocrinology, 147(5), 617-624.
Practice Committee of the American Society for Reproductive Medicine. (2008). Gonadotropin preparations: past, present, and future perspectives.. Fertility and Sterility, 90(5 Suppl), S13-S20.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups
